Lineage Cell Therapeutics, Inc. financial data

Symbol
LCTX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
2173 Salk Avenue, Suite 200, Carlsbad, California
State of incorporation
California
Fiscal year end
December 31
Former names
BIOTIME INC (to 8/8/2019)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 264 % -12.1%
Debt-to-equity 56.6 % -15.3%
Return On Equity -34.9 % -11.2%
Return On Assets -22.1 % -18.4%
Operating Margin -309 % -61%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 189 M shares +10.8%
Common Stock, Shares, Outstanding 189 M shares +10.9%
Entity Public Float 186 M USD -7.48%
Common Stock, Value, Issued 467 M USD +5.73%
Weighted Average Number of Shares Outstanding, Basic 183 M shares +7.51%
Weighted Average Number of Shares Outstanding, Diluted 183 M shares +7.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8 M USD -32.5%
Revenue from Contract with Customer, Excluding Assessed Tax 1.44 M USD -39.5%
Cost of Revenue 650 K USD -3.13%
Research and Development Expense 14.5 M USD -4.31%
General and Administrative Expense 17.6 M USD -6.33%
Costs and Expenses 8.11 M USD -10.2%
Operating Income (Loss) -24.8 M USD -8.72%
Nonoperating Income (Expense) 1.12 M USD -76.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -23.6 M USD +5.19%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -23.7 M USD -0.42%
Earnings Per Share, Basic -0.14 USD/shares 0%
Earnings Per Share, Diluted -0.14 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 43.6 M USD +182%
Marketable Securities, Current 45 K USD -99.9%
Accounts Receivable, after Allowance for Credit Loss, Current 77 K USD
Assets, Current 45.7 M USD -7.93%
Property, Plant and Equipment, Net 2.1 M USD -62.3%
Operating Lease, Right-of-Use Asset 2.86 M USD
Intangible Assets, Net (Excluding Goodwill) 46.5 M USD -0.26%
Goodwill 10.7 M USD 0%
Assets 108 M USD -4.17%
Accounts Payable, Current 2.21 M USD -26.3%
Employee-related Liabilities, Current 2.48 M USD +37.1%
Accrued Liabilities, Current 991 K USD +145%
Contract with Customer, Liability, Current 10.1 M USD -72.4%
Liabilities, Current 16.9 M USD -1.95%
Contract with Customer, Liability, Noncurrent 21.2 M USD
Deferred Income Tax Liabilities, Net 273 K USD 0%
Operating Lease, Liability, Noncurrent 2.07 M USD -18.4%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 37.5 M USD -15.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.77 M USD +10.8%
Retained Earnings (Accumulated Deficit) -391 M USD -6.43%
Stockholders' Equity Attributable to Parent 72.4 M USD +2.77%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 71 M USD +2.86%
Liabilities and Equity 108 M USD -4.17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.78 M USD +48.6%
Net Cash Provided by (Used in) Financing Activities 14 M USD +1402000%
Net Cash Provided by (Used in) Investing Activities -38 K USD -100%
Common Stock, Shares Authorized 450 M shares +80%
Common Stock, Shares, Issued 189 M shares +10.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.13 M USD +99%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 44.1 M USD +175%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2 K USD 0%
Deferred Tax Assets, Valuation Allowance 80.5 M USD +2.95%
Deferred Tax Assets, Gross 85.2 M USD +8.3%
Operating Lease, Liability 3.13 M USD
Payments to Acquire Property, Plant, and Equipment 38 K USD -79.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -23.3 M USD -8.07%
Lessee, Operating Lease, Liability, to be Paid 2.38 M USD
Operating Lease, Liability, Current 1.05 M USD +15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 508 K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 531 K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 330 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 486 K USD
Deferred Tax Assets, Operating Loss Carryforwards 63.5 M USD +7.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2 M shares 0%
Unrecognized Tax Benefits 2.96 M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 407 K USD
Operating Lease, Payments 302 K USD -4.13%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 22 K USD -33.3%
Depreciation, Depletion and Amortization 138 K USD -8%
Deferred Tax Assets, Net of Valuation Allowance 4.73 M USD +847%
Share-based Payment Arrangement, Expense 1.16 M USD +12.8%